what happened to amlx:Amylyx's approved ALS drug flunks crucial test
Amylyx's approved ALS drug flunks crucial test
2024年3月8日—AmylyxPharmaceuticalsisconsideringwithdrawingitstreatmentforamyotrophiclateralsclerosisfromthemarketafterthedrugfailedto ...。其他文章還包含有:「AmylyxPharmaceuticalsstockdrops80%afterALSdrug...」、「Amylyx's(AMLX)ALSDrugFailsPivotalStudy」、「AmylyxPlummetsasALSDrugFailstoBenefitPatients」、「AmylyxPharmaceuticals」、「AMLXStockCrashesAsPatientsDropOffALSDrug...」、「AmylyxP...
查看更多 離開網站Amylyx Pharmaceuticals stock drops 80% after ALS drug ...
https://www.marketwatch.com
Amylyx Pharmaceuticals shares dropped more than 80% early Friday after the company said its ALS treatment Relyvrio failed a late-stage trial ...
Amylyx's (AMLX) ALS Drug Fails Pivotal Study
https://finance.yahoo.com
Shares of Amylyx Pharmaceuticals AMLX nosedived 82.2% on Mar 8 after management announced topline results from the phase III PHOENIX study evaluating Relyvrio.
Amylyx Plummets as ALS Drug Fails to Benefit Patients
https://www.bloomberg.com
Amylyx Pharmaceuticals Inc. plummeted as its drug for amyotrophic lateral sclerosis failed to benefit patients in a trial.
Amylyx Pharmaceuticals
https://finance.yahoo.com
Amylyx acquired the hyperinsulinemic hypoglycaemia GLP1-RA candidate after previous developers Eiger filed for bankruptcy. Clinical Trials Arena • 2 months ago.
AMLX Stock Crashes As Patients Drop Off ALS Drug ...
https://www.investors.com
Amylyx missed Wall Street's expectations on Thursday amid struggles for its amyotrophic lateral sclerosis drug, and AMLX stock crashed.
Amylyx Pharmaceuticals
https://seekingalpha.com
Amylyx faces challenges after a failed drug, but management is optimistic with a strong balance sheet and new opportunities for investors.
Amylyx ALS drug fails crucial study
https://www.biopharmadive.com
A large clinical trial meant to confirm the benefits of a new ALS medication has instead failed, dealing a major blow to the therapy's developer as well as ...
Amylyx Stock Crashes After ALS Treatment Fails In Its ...
https://www.investors.com
Amylyx stock crashed Friday, losing almost all of its value, after the company said its approved ALS treatment, Relyvrio, failed in a pivotal study.
Amylyx Pharma to remove ALS drug from US
https://www.reuters.com
Amylyx Pharmaceuticals (AMLX.O) will withdraw its amyotrophic lateral sclerosis (ALS) drug - its only product in the market - from the US and Canada.